TRIN Q1 2026 Earnings Slight EPS Beat Amidst Stock Decline ENSG Q1 2026 Earnings Narrow EPS Miss Meets Slight Share Price Uptick NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure MRCY Q1 2026 Earnings Massive EPS Beat Drives Stock Higher IMRX Q1 2026 Earnings EPS Beat Estimates by 183 as Clinical Pipeline Advances SRXH Q2 2025 Earnings EPS Loss of 074 and No Revenue Reported Weigh on Sentiment